CD248 and cancer: High expression of CD248 was significantly associated with poor overall survival in several types of cancer (Figure 3A), including GBM (HR = 1.6, P = 0.012) (Figure 3B), KIRP (HR = 1.9, P = 0.049) (Figure 3C), LGG (HR = 3.1, P < 0.001) (Figure 3D), and LUSC (HR = 1.4, P = 0.023) (Figure 3E).